US equities
|
MU
$903.70
▲+0.00%
META
$630.56
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
SKHY
$142.62
▲+0.00%
TSLA
$391.62
▲+0.00%
INTC
$90.47
▲+0.00%
NVDA
$216.00
▲+0.00%
MU
$903.70
▲+0.00%
META
$630.56
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
SKHY
$142.62
▲+0.00%
TSLA
$391.62
▲+0.00%
INTC
$90.47
▲+0.00%
NVDA
$216.00
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Steven Brugger
Recent news which mentions Steven Brugger
GlaxoSmithKline to buy vaccine developer with 'potentially disruptive technology' in deal worth up to $3.3B
May 31, 2022
Tags
Pharmaceuticals
GlaxoSmithKline PLC
Biotech
From
Business Journals